
Cordon Blue Pharma Private Limited
Founded in 2014 and headquartered in Delhi, India.
Founded in 2014 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
U24110DL2014PTC269477
269477
Private Limited Indian Non-Government Company
25 Jul 2014
30 Sep 2016
31 Mar 2016
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Priya Ranjan ![]() | Director | 25-Jul-2014 | Current |
Rajni ![]() | Director | 25-Jul-2014 | Current |
Bina Mathur ![]() | Director | 25-Jul-2014 | Current |
Enhance accessibility to Cordon Blue Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2016, Cordon Blue Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Priya Ranjan is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cordon Blue Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cordon Blue Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cordon Blue Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cordon Blue Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.
Cordon Blue Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi.
Priya Ranjan was appointed as a Director was appointed as a Director on 25 Jul 2014 & has been associated with this company since 10 years 7 months .
Rajni was appointed as a Director was appointed as a Director on 25 Jul 2014 & has been associated with this company since 10 years 7 months .
Bina Mathur was appointed as a Director was appointed as a Director on 25 Jul 2014 & has been associated with this company since 10 years 7 months .
Cordon Blue Pharma Private Limited was registered on 25 Jul 2014 with Roc Delhi & aged 10 years 7 months as per MCA records.
Cordon Blue Pharma Private Limited was incorporated on 25 Jul 2014.
The authorized share capital of Cordon Blue Pharma Private Limited is ₹ 2.50 M and paid-up capital is ₹ 1.89 M.
Currently 3 directors are associated with Cordon Blue Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cordon Blue Pharma Private Limited is Plot No. L-23 Mahipalpur, Nh-8 India, New Delhi, 110037.
The corporate identification number (CIN) of Cordon Blue Pharma Private Limited is U24110DL2014PTC269477 and the company number is 269477 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Cordon Blue Pharma Private Limited was filed with the ROC on 31 Mar 2016.
Search company & director profiles for free and gain access to critical business data.